Results 1 to 10 of about 603,581 (184)
SARS‐CoV‐2 and hypertension [PDF]
Physiological Reports, 2021 The objective of this review is to give an overview of the pathophysiological effects of the Coronavirus Disease 2019 (COVID‐19) in relation to hypertension (HT), with a focus on the Renin–Angiotensin–Aldosterone System (RAAS) and the MAS receptor. HT is
Briyanth Ravichandran +5 more
doaj +4 more sources
Gefässchirurgie, 2020 The year 2020 has been marked by the novel coronavirus, named Severe Acute Respiratory Syndrome 2 (SARS-CoV-2), which causes coronavirus disease COVID-19. The World Health Organization (WHO) declared a global pandemic on the 11th of March 2020 due to the spread of this very contagious virus throughout the world.
Steinbauer, M., Böckler, D.
+9 more sources
One Health, 2021 COVID-19 pandemic has challenged public health systems worldwide, particularly affecting developing countries in Latin America like Ecuador. In this report, we exposed the fundamental role of the Ecuadorian universities to improve COVID-19 surveillance ...
Daniela Santander-Gordon +19 more
doaj +1 more source
Infectious Disease Clinics of North America, 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in 2020 and has led to an unprecedented global pandemic. Understanding the virology behind SARS-CoV-2 infection has provided key insights into our efforts to develop antiviral agents and control the COVID-19 pandemic.
Li, Yijia, Li, Jonathan Z.
openaire +3 more sources
Frontiers in Microbiology, 2021 Since the emergence of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in December 2019, the scientific community has been sharing data on epidemiology, diagnostic methods, and whole-genomic sequences almost in real time. The latter have
Annika Brinkmann +9 more
doaj +1 more source
Scientific Reports, 2022 There is widespread concern about the clinical effectiveness of current vaccines in preventing Covid-19 caused by SARS-CoV-2 Variants of Concern (Williams in Lancet Respir Med 29:333–335, 2021; Hayawi in Vaccines 9:1305, 2021), including those identified
Spyros A. Charonis +2 more
doaj +1 more source
Scientific Reports, 2022 High-throughput detection of neutralizing antibodies against SARS-CoV-2 presents a valuable tool for vaccine trials or investigations of population immunity.
Natalie Hofmann +4 more
doaj +1 more source
Epidemiology of SARS-CoV-2 [PDF]
Infection, 2020 Abstract Purpose SARS-CoV-2 is a recently emerged ß-coronavirus. Here we present the current knowledge on its epidemiologic features. Methods Non-systematic review.
Salzberger, Bernd +7 more
openaire +4 more sources
BMC Infectious Diseases, 2022 Background SARS-CoV-2 cases in Germany increased in early March 2020. By April 2020, cases among health care workers (HCW) were detected across departments at a tertiary care hospital in Berlin, prompting a longitudinal investigation to assess HCW SARS ...
Sara Tomczyk +11 more
doaj +1 more source